AUCTA PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, August 1, 2018, a trademark application was filed for AUCTA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the AUCTA PHARMACEUTICALS trademark a serial number of 88061928. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 4, 2022. This trademark is owned by Aucta Pharmaceuticals, Inc.. The AUCTA PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of seizures, bipolar disorders, depression and neurofibromatosis; Pharmaceutical preparations for the prevention and treatment of central nervous system disorders, neurological diseases and disorders, neurodegenerative disorders, and depression
aucta pharmaceuticals

General Information

Serial Number88061928
Word MarkAUCTA PHARMACEUTICALS
Filing DateWednesday, August 1, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 1, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of seizures, bipolar disorders, depression and neurofibromatosis; Pharmaceutical preparations for the prevention and treatment of central nervous system disorders, neurological diseases and disorders, neurodegenerative disorders, and depression
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 8, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAucta Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPiscataway, NJ 08854
Party NameAucta Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Brunswick, NJ 08902

Trademark Events

Event DateEvent Description
Monday, April 4, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 31, 2021EXTENSION 5 GRANTED
Thursday, August 26, 2021EXTENSION 5 FILED
Tuesday, August 31, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 26, 2021TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 26, 2021EXTENSION 4 GRANTED
Friday, February 26, 2021EXTENSION 4 FILED
Friday, February 26, 2021TEAS EXTENSION RECEIVED
Thursday, August 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 25, 2020EXTENSION 3 GRANTED
Tuesday, August 25, 2020EXTENSION 3 FILED
Tuesday, August 25, 2020TEAS EXTENSION RECEIVED
Friday, February 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 26, 2020EXTENSION 2 GRANTED
Wednesday, February 26, 2020EXTENSION 2 FILED
Wednesday, February 26, 2020TEAS EXTENSION RECEIVED
Wednesday, August 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 26, 2019EXTENSION 1 GRANTED
Monday, August 26, 2019EXTENSION 1 FILED
Monday, August 26, 2019TEAS EXTENSION RECEIVED
Monday, August 26, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 26, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 1, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 12, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 20, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, November 18, 2018ASSIGNED TO EXAMINER
Wednesday, August 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 4, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals aucta disorders depression pharmaceutical treatment preparations system neurological diseases neurodegenerative nervous